ZNF765
gene geneOn this page
Summary
ZNF765 (zinc finger protein 765, HGNC:25092) is a protein-coding gene on chromosome 19q13.42, encoding Zinc finger protein 765 (Q7L2R6). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 91661 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 92 total
- MANE Select transcript:
NM_001040185
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25092 |
| Approved symbol | ZNF765 |
| Name | zinc finger protein 765 |
| Location | 19q13.42 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000196417 |
| Ensembl biotype | protein_coding |
| Entrez | 91661 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 5 protein_coding, 3 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000396408, ENST00000504146, ENST00000504235, ENST00000505866, ENST00000507045, ENST00000594030, ENST00000594627, ENST00000596086, ENST00000933978, ENST00000963919
RefSeq mRNA: 2 — MANE Select: NM_001040185
NM_001040185, NM_001350495
CCDS: CCDS46171
Canonical transcript exons
ENST00000396408 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001524825 | 53407698 | 53412009 |
| ENSE00002055262 | 53395149 | 53395193 |
| ENSE00003283638 | 53402065 | 53402191 |
| ENSE00003557175 | 53397943 | 53398030 |
Expression profiles
Bgee: expression breadth ubiquitous, 246 present calls, max score 90.92.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.3438 / max 57.4145, expressed in 1190 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177325 | 6.1489 | 1654 |
| 177324 | 3.3438 | 1190 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 90.92 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 90.50 | gold quality |
| secondary oocyte | CL:0000655 | 89.75 | gold quality |
| thymus | UBERON:0002370 | 87.80 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 87.75 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 84.54 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 84.18 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.52 | gold quality |
| adrenal tissue | UBERON:0018303 | 82.52 | gold quality |
| jejunal mucosa | UBERON:0000399 | 82.37 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 82.12 | gold quality |
| parietal pleura | UBERON:0002400 | 81.56 | gold quality |
| amniotic fluid | UBERON:0000173 | 81.37 | gold quality |
| tibia | UBERON:0000979 | 81.21 | gold quality |
| colonic mucosa | UBERON:0000317 | 81.10 | gold quality |
| visceral pleura | UBERON:0002401 | 80.94 | gold quality |
| gingival epithelium | UBERON:0001949 | 80.84 | gold quality |
| lower lobe of lung | UBERON:0008949 | 80.84 | gold quality |
| placenta | UBERON:0001987 | 80.69 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.24 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.08 | gold quality |
| ovary | UBERON:0000992 | 79.97 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 79.57 | gold quality |
| calcaneal tendon | UBERON:0003701 | 79.54 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 79.54 | gold quality |
| oral cavity | UBERON:0000167 | 79.46 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 79.23 | gold quality |
| gingiva | UBERON:0001828 | 79.00 | gold quality |
| bone marrow | UBERON:0002371 | 78.89 | gold quality |
| islet of Langerhans | UBERON:0000006 | 78.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.69 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- IGF2BP2 stabilized FBXL19-AS1 regulates the blood-tumour barrier permeability by negatively regulating ZNF765 by STAU1-mediated mRNA decay. (PMID:32713259)
Cross-species orthologs
0 orthologs
Paralogs (11): ZNF761 (ENSG00000160336), ZNF701 (ENSG00000167562), ZNF816 (ENSG00000180257), ZNF766 (ENSG00000196214), ZNF860 (ENSG00000197385), ZNF813 (ENSG00000198346), ZNF525 (ENSG00000203326), ZNF468 (ENSG00000204604), ZNF888 (ENSG00000213793), ZNF578 (ENSG00000258405), (ENSG00000269825)
Protein
Protein identifiers
Zinc finger protein 765 — Q7L2R6 (reviewed: Q7L2R6)
All UniProt accessions (3): Q7L2R6, D6RF03, E9PDE6
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7L2R6-1 | 1 | yes |
| Q7L2R6-2 | 2 | |
| Q7L2R6-3 | 3 |
RefSeq proteins (2): NP_001035275, NP_001337424 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050758 | Znf_C2H2-type | Family |
Pfam: PF00096, PF01352
UniProt features (25 total): zinc finger region 11, sequence conflict 6, splice variant 4, chain 1, domain 1, cross-link 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7L2R6-F1 | 63.84 | 0.04 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 205
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins |
MSigDB gene sets: 66 (showing top):
LIAO_METASTASIS, MODULE_544, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, JOHNSTONE_PARVB_TARGETS_3_DN, MODULE_481, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ELF2_TARGET_GENES, ZNF350_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR4698, MIR23A_3P_MIR23B_3P, MIR23C
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), nuclear lumen (GO:0031981)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Regulation of endogenous retroelements | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nucleus | 1 |
| intracellular organelle lumen | 1 |
Protein interactions and networks
STRING
484 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF765 | FAAH2 | Q6GMR7 | 525 |
| ZNF765 | PDXDC1 | Q6P996 | 516 |
| ZNF765 | PDHB | P11177 | 359 |
| ZNF765 | VOPP1 | Q96AW1 | 322 |
| ZNF765 | STAU1 | O95793 | 305 |
| ZNF765 | ADAP1 | O75689 | 299 |
| ZNF765 | BAIAP3 | O94812 | 277 |
| ZNF765 | ABHD3 | Q8WU67 | 276 |
| ZNF765 | N4BP2L2 | Q92802 | 269 |
| ZNF765 | ENOPH1 | Q9UHY7 | 267 |
| ZNF765 | CEP295 | Q9C0D2 | 263 |
| ZNF765 | HOOK2 | Q96ED9 | 251 |
| ZNF765 | MED11 | Q9P086 | 250 |
| ZNF765 | C9orf153 | Q5TBE3 | 248 |
| ZNF765 | RAX2 | Q96IS3 | 248 |
IntAct
22 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF765 | TRIM28 | psi-mi:“MI:0915”(physical association) | 0.620 |
| ZNF765 | REL | psi-mi:“MI:0915”(physical association) | 0.560 |
| DZIP3 | ZNF765 | psi-mi:“MI:0915”(physical association) | 0.560 |
| USHBP1 | ZNF765 | psi-mi:“MI:0915”(physical association) | 0.560 |
| REL | ZNF765 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF765 | DZIP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF765 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF765 | IPO7 | psi-mi:“MI:0915”(physical association) | 0.500 |
| tax | ZNF765 | psi-mi:“MI:0915”(physical association) | 0.490 |
| ZNF765 | tax | psi-mi:“MI:0915”(physical association) | 0.490 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| ZNF765 | TRIM24 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF467 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN5 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| CUL9 | NVL | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (23): ZNF765 (Two-hybrid), ZNF765 (Two-hybrid), ZNF765 (Two-hybrid), ZNF765 (Affinity Capture-MS), ZNF765 (Affinity Capture-RNA), ZNF765 (Two-hybrid), ZNF765 (Two-hybrid), ZNF765 (Two-hybrid), ZNF765 (Two-hybrid), ZNF765 (Two-hybrid), ZNF765 (Two-hybrid), ZNF765 (Two-hybrid), ZNF765 (Two-hybrid), ZNF765 (Two-hybrid), ARID5A (Two-hybrid)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
92 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
679 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:53395190:GCGG:G | donor_gain | 1.0000 |
| 19:53395192:GG:G | donor_gain | 1.0000 |
| 19:53395192:GGGTG:G | donor_loss | 1.0000 |
| 19:53395193:GG:G | donor_gain | 1.0000 |
| 19:53395194:G:GA | donor_loss | 1.0000 |
| 19:53395194:G:GG | donor_gain | 1.0000 |
| 19:53395195:T:A | donor_loss | 1.0000 |
| 19:53402152:G:T | donor_gain | 1.0000 |
| 19:53395189:CGCGG:C | donor_gain | 0.9900 |
| 19:53395190:GCGGG:G | donor_gain | 0.9900 |
| 19:53395191:CGG:C | donor_gain | 0.9900 |
| 19:53395192:GGG:G | donor_gain | 0.9900 |
| 19:53398029:AGGT:A | donor_loss | 0.9900 |
| 19:53398030:GGTGA:G | donor_loss | 0.9900 |
| 19:53398031:G:GA | donor_loss | 0.9900 |
| 19:53398032:T:G | donor_loss | 0.9900 |
| 19:53397940:CA:C | acceptor_loss | 0.9800 |
| 19:53397941:A:AG | acceptor_gain | 0.9800 |
| 19:53397942:G:GG | acceptor_gain | 0.9800 |
| 19:53397942:GGATT:G | acceptor_gain | 0.9800 |
| 19:53402190:GG:G | donor_gain | 0.9800 |
| 19:53402191:GG:G | donor_gain | 0.9800 |
| 19:53402197:G:GT | donor_gain | 0.9800 |
| 19:53402215:G:GT | donor_gain | 0.9800 |
| 19:53404549:TTC:T | donor_gain | 0.9800 |
| 19:53397941:AG:A | acceptor_gain | 0.9700 |
| 19:53397942:GG:G | acceptor_gain | 0.9700 |
| 19:53402152:G:GT | donor_gain | 0.9700 |
| 19:53402215:G:T | donor_gain | 0.9700 |
| 19:53402059:T:G | acceptor_loss | 0.9600 |
AlphaMissense
3523 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:53408561:T:C | F336L | 0.993 |
| 19:53408563:T:A | F336L | 0.993 |
| 19:53408563:T:G | F336L | 0.993 |
| 19:53408645:T:C | F364L | 0.990 |
| 19:53408647:T:A | F364L | 0.990 |
| 19:53408647:T:G | F364L | 0.990 |
| 19:53408729:T:C | F392L | 0.989 |
| 19:53408731:T:A | F392L | 0.989 |
| 19:53408731:T:G | F392L | 0.989 |
| 19:53408393:T:C | F280L | 0.988 |
| 19:53408395:C:A | F280L | 0.988 |
| 19:53408395:C:G | F280L | 0.988 |
| 19:53408477:T:C | F308L | 0.985 |
| 19:53408479:C:A | F308L | 0.985 |
| 19:53408479:C:G | F308L | 0.985 |
| 19:53408978:T:C | F475L | 0.983 |
| 19:53408980:C:A | F475L | 0.983 |
| 19:53408980:C:G | F475L | 0.983 |
| 19:53408652:G:C | R366P | 0.975 |
| 19:53408580:T:C | L342P | 0.974 |
| 19:53409062:T:C | F503L | 0.968 |
| 19:53409064:C:A | F503L | 0.968 |
| 19:53409064:C:G | F503L | 0.968 |
| 19:53402089:G:C | A14P | 0.967 |
| 19:53408588:C:G | H345D | 0.967 |
| 19:53402098:T:C | F17L | 0.964 |
| 19:53402100:C:A | F17L | 0.964 |
| 19:53402100:C:G | F17L | 0.964 |
| 19:53408562:T:C | F336S | 0.963 |
| 19:53408590:T:A | H345Q | 0.963 |
dbSNP variants (sampled 300 via entrez): RS1000217926 (19:53414615 T>G), RS1000246805 (19:53398593 T>C), RS1000273355 (19:53414189 C>G,T), RS1000380595 (19:53419529 G>A,T), RS1000445332 (19:53425132 C>G,T), RS1000472790 (19:53417100 G>A,T), RS1000563417 (19:53413201 T>A,C), RS1000615744 (19:53413001 T>C), RS1000672592 (19:53418626 G>A,C), RS1000769842 (19:53423890 C>T), RS1000822298 (19:53423497 C>T), RS1001008866 (19:53419925 A>G), RS1001127224 (19:53418442 C>T), RS1001132975 (19:53398437 G>A), RS1001277612 (19:53415525 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| avobenzone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| jinfukang | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Succimer | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
| Magnetite Nanoparticles | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.